These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2272190)

  • 1. Efficacy and tolerability of controlled-release trazodone in depression: a large multicentre study in general practice.
    Moon CA; Laws D; Stott PC; Hayes G
    Curr Med Res Opin; 1990; 12(3):160-8. PubMed ID: 2272190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The drug treatment of depression in general practice: a comparison of nocte administration of trazodone with mianserin, dothiepin and amitriptyline.
    Blacker R; Shanks NJ; Chapman N; Davey A
    Psychopharmacology (Berl); 1988; 95 Suppl():S18-24. PubMed ID: 3133708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of conventional and controlled-release formulations of trazodone in elderly depressed patients.
    Bayer AJ; Pathy MS; Cameron A; Venkateswalu T; Ather SA; Mankikar GD; Ghosh AK
    Clin Neuropharmacol; 1989; 12 Suppl 1():S50-5; Discussion S56-7. PubMed ID: 2663153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of mixed affective disorders in general practice: a comparison of trazodone and dothiepin.
    Moon CA; Chapman JP; Healey JC; Hannington JA
    Curr Med Res Opin; 1990; 12(1):34-42. PubMed ID: 2188795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of prolonged-release trazodone in major depressive disorder: a multicenter, randomized, double-blind, flexible-dose trial.
    Zhang L; Xie WW; Li LH; Zhang HG; Wang G; Chen DC; Cao Y; Cui LJ; Zhang KR; Shi JG; Tan QR; Zheng HB; Xu XF; Cheng ZH; Zhao JP
    Pharmacology; 2014; 94(5-6):199-206. PubMed ID: 25376160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two oral dosage regimens of 150 mg trazodone in the treatment of depression in general practice.
    Davey A
    Psychopharmacology (Berl); 1988; 95 Suppl():S25-30. PubMed ID: 3133709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trazodone, a triazolopyridine derivative, in primary depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1980 Jul; 41(7):250-5. PubMed ID: 6993447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and residual effects of trazodone (150 mg nocte) and mianserin in the treatment of depressed general practice patients.
    Moon CA; Davey A
    Psychopharmacology (Berl); 1988; 95 Suppl():S7-13. PubMed ID: 3133716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
    Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential dosing of trazodone in elderly depressed patients: a study to investigate optimal dosing.
    Mukherjee PK; Davey A
    J Int Med Res; 1986; 14(5):279-84. PubMed ID: 3533676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new sustained-release formulation of trazodone for treatment of minor psychopathological depression. A controlled study].
    Piccione M
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):169-74. PubMed ID: 2799002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trazodone and mianserin in general practice.
    Beaumont G; Gringras M; Ankier SI
    Psychopathology; 1984; 17 Suppl 2():24-9. PubMed ID: 6371875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of trazodone retard monotherapy: results of the Serbian non-interventional study.
    Miljevic CD; Lečić-Toševski D; Trazodone Study Group Serbia
    Int J Psychiatry Clin Pract; 2016 Sep; 20(3):133-40. PubMed ID: 27335239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trazodone, a new antidepressant: efficacy and safety in endogenous depression.
    Kellams JJ; Klapper MH; Small JG
    J Clin Psychiatry; 1979 Sep; 40(9):390-5. PubMed ID: 383704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
    J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trazodone--a comparison of single night-time and divided daily dosage regimens.
    Brooks D; Prothero W; Bouras N; Bridges PK; Jarman CM; Ankier SI
    Psychopharmacology (Berl); 1984; 84(1):1-4. PubMed ID: 6436874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.